ACCESSION: MSBNK-SMB_Measured-HSA014P0228002
RECORD_TITLE: Characterized; 12-amino-7-oxododecanoic acid; LC-ESI-QFT; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'Blanc1-neg_6172': {'bp': 66107.0, 'sum': 176738.0}, 'Blanc1-neg_6209': {'bp': 54344.0, 'sum': 133520.0}, 'EL05-neg_5281': {'bp': 44589.0, 'sum': 120904.0}, 'EL09-neg_5278': {'bp': 43572.0, 'sum': 113527.0}, 'EL11-neg_5256': {'bp': 42164.0, 'sum': 96100.0}, 'EL07-neg_5263': {'bp': 40313.0, 'sum': 103781.0}, 'EL06-neg_5286': {'bp': 40305.0, 'sum': 116557.0}, 'EL16-neg_5266': {'bp': 39034.0, 'sum': 87516.0}, 'EL20-neg_5280': {'bp': 36539.0, 'sum': 103816.0}, 'EL02-neg_5324': {'bp': 35566.0, 'sum': 106663.0}, 'EL23-neg_5271': {'bp': 33019.0, 'sum': 99410.0}, 'EL10-neg_5280': {'bp': 31251.0, 'sum': 97247.0}, 'EL21-neg_5276': {'bp': 28296.0, 'sum': 69728.0}, 'EL04-neg_5261': {'bp': 27220.0, 'sum': 82225.0}}
COMMENT: RETENTION_TIME_STDEV 0.513
COMMENT: PRECURSOR_M/Z_RAW 228.160023
COMMENT: PRECURSOR_M/Z_STDEV 0.000088
COMMENT: PRECURSOR_IN_MS1 mz 228.160498; int 18.767; delta(ppm) 1.072968
COMMENT: PROPOSED_CHARGE_STATE -1; mz 229.163832; int 2.276; cor 0.745
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.096; C12H23NO3; [M-H]1; delta(ppm) -0.096000
COMMENT: PROPOSED_MF MS-FINDER 3.908; C12H23NO3; [M-H]-; delta(ppm) -0.092808
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.290; C12H23NO3; [M-H]-; delta(ppm) -0.092808
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C12H23NO3; [M-H]-; delta(ppm) -0.092808
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.961; C12H23NO3; [M-H]-; delta(ppm) -0.092808
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.728; C10H21N4O2; [M-H]-; delta(ppm) 5.791958
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.998; C12H23NO3; [M-H]-; delta(ppm) -0.092808
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C10H21N4O2; [M-H]-; delta(ppm) 5.791958
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.556; WRRYZYASRAUROW-UHFFFAOYSA-N; [M-H]-; CCCCCCCCCC(=O)NCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.375; QECNYUPEJKKJSK-UHFFFAOYSA-N; [M-H]-; O=C(N(CCCO)C1CCOC(C)(C)C1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.300; QLHULAHOXSSASE-UHFFFAOYNA-N; [M-H]-; CCC(C)OC(=O)N1CCCCC1CCO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.182; DVFBBRGYRFXMCJ-PGNYGABRNA-N; [M-H]-; CCC[C@@H](O)[C@H](O)\C=C\C(=O)NCC(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.921; WRRYZYASRAUROW-UHFFFAOYSA-N; [M-H]-; N-Decanoylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.921; QLHULAHOXSSASE-UHFFFAOYNA-N; [M-H]-; Icaridin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.817; DVFBBRGYRFXMCJ-PGNYGABRNA-N; [M-H]-; UNPD63456
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.765; QECNYUPEJKKJSK-UHFFFAOYSA-N; [M-H]-; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WRRYZYASRAUROW-UHFFFAOYSA-N; [M-H]-; N-Decanoylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; QLHULAHOXSSASE-UHFFFAOYNA-N; [M-H]-; Icaridin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; DVFBBRGYRFXMCJ-PGNYGABRNA-N; [M-H]-; UNPD63456
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; QECNYUPEJKKJSK-UHFFFAOYSA-N; [M-H]-; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; QLHULAHOXSSASE-UHFFFAOYSA-N; [M-H]-; butan-2-yl 2-(2-hydroxyethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; ZYUIIFJKSLWWHG-UHFFFAOYSA-N; [M-H]-; 12-amino-7-oxododecanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; MXGVEVVBSGUZSO-UHFFFAOYSA-N; [M-H]-; tert-butyl 3-amino-2-(oxan-4-yl)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.468; YBNJZIDYXCGAPX-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-(2-hydroxyethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.255; SGNKPJPMWHKOJO-UHFFFAOYSA-N; [M-H]-; tert-butyl N-[4-(hydroxymethyl)cyclohexyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.251; LTVQOFUGXMVESU-JTQLQIEISA-N; [M-H]-; tert-butyl (2S)-2-(2-hydroxyethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.206; SQOMPUDOUGDJPH-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-(1-hydroxyethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.203; XWYVCQSOGJIMPK-UHFFFAOYSA-N; [M-H]-; tert-butyl N-[(4-hydroxycyclohexyl)methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.202; YFYSPIRFZKBBAU-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-(hydroxymethyl)-4-methylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.202; WRRYZYASRAUROW-UHFFFAOYSA-N; [M-H]-; 2-(decanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.188; LBJSEPNOVVUVJA-UHFFFAOYSA-N; [M-H]-; tert-butyl N-[3-(hydroxymethyl)cyclohexyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.182; DXABICKZWDHPIP-UHFFFAOYSA-N; [M-H]-; tert-butyl 3-(2-hydroxyethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.182; QZMUVNRDYLNZDA-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-hydroxy-3,3-dimethylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.180; MWQYHQBSFLBACS-UHFFFAOYSA-N; [M-H]-; (7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decan-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.179; GVQRDYUYIXDJSG-UHFFFAOYSA-N; [M-H]-; tert-butyl N-[1-(hydroxymethyl)cyclohexyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.179; KDOINXYPVJQGPE-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.176; XUFBETUUQRMWRY-UWVGGRQHSA-N; [M-H]-; tert-butyl N-[(1S,2R)-2-(hydroxymethyl)cyclohexyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.176; CBZNOKAFOMSSLW-OPRDCNLKSA-N; [M-H]-; tert-butyl N-[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.175; RNQIRWQBYRTJPG-RKDXNWHRSA-N; [M-H]-; tert-butyl (2R,6R)-4-hydroxy-2,6-dimethylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.174; MFZDEMSNUTXFJE-UHFFFAOYSA-N; [M-H]-; tert-butyl 3-(1-hydroxyethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.174; CMUYBJHYEACLSY-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-(hydroxymethyl)azepane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.170; MHDYJJCYEVKSPT-UHFFFAOYSA-N; [M-H]-; hexyl 2-(diethylamino)-2-oxoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.170; NJSSRXJRYDPOKU-UHFFFAOYSA-N; [M-H]-; 2-morpholin-4-ylethyl 3,3-dimethylbutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.169; LXOVPEAYTWFSBI-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-(hydroxymethyl)-2-methylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.169; FJHPEVGAZVQMHL-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-hydroxy-2-propan-2-ylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.169; SYCPWHUVXAZZPW-NXEZZACHSA-N; [M-H]-; tert-butyl N-[(1R,2R)-2-hydroxycyclohexyl]-N-methylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.168; MAONMXZZIKVZBB-UHFFFAOYSA-N; [M-H]-; tert-butyl N-[(2-hydroxycyclohexyl)methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.168; SZVLDQVHEROQDA-OPRDCNLKSA-N; [M-H]-; tert-butyl N-[(1R,3R,4R)-4-hydroxy-3-methylcyclohexyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.168; PXSPQTFERASGAD-UHFFFAOYSA-N; [M-H]-; tert-butyl N-(5-methyl-1-oxohexan-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.168; SMXWYFOFHXCBPN-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-hydroxy-2,5-dimethylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.168; LAAWJBZTSKAZNN-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-hydroxy-3,5-dimethylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; BNMWVRRRNYUWBT-UHFFFAOYSA-N; [M-H]-; tert-butyl 2-(hydroxymethyl)-2-methylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; SIAYMOIYVZXQNT-ZJUUUORDSA-N; [M-H]-; tert-butyl (3R,4S)-3-hydroxy-4-propan-2-ylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; RKOVACICPIRRED-UHFFFAOYSA-N; [M-H]-; ethyl 4-(dipropylamino)-4-oxobutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; MMJRNJZURLUGLO-UHFFFAOYSA-N; [M-H]-; [2-(hydroxymethyl)-2-methylpentyl] N-(2-methylprop-2-enyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; OQFJRLGCJUCVQG-UHFFFAOYSA-N; [M-H]-; 2-(dimethylamino)ethyl 1-hydroxycycloheptane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; ZFSQNMDPGDNXOY-UHFFFAOYSA-N; [M-H]-; 2-(dimethylamino)ethyl 2-cyclohexyloxyacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; DORQCCNLYAGUSQ-UHFFFAOYSA-N; [M-H]-; tert-butyl N-(2-formyl-4-methylpentyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; FXVLUNMZSAJYNE-NXEZZACHSA-N; [M-H]-; tert-butyl N-[(1R,2R)-2-hydroxycycloheptyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; PJBMOVBTDXMMOH-UHFFFAOYSA-N; [M-H]-; tert-butyl 3-(methoxymethyl)piperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; IHXPPFQXYWBYLL-UHFFFAOYSA-N; [M-H]-; tert-butyl N-[1-(hydroxymethyl)-3,3-dimethylcyclobutyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; KQKKCSGNMNTPCA-UHFFFAOYSA-N; [M-H]-; tert-butyl 3-(2-hydroxy-2-methylpropyl)azetidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; OJYZYWNWTHPMGT-ZJUUUORDSA-N; [M-H]-; tert-butyl N-[[(1R,3S)-3-hydroxycyclohexyl]methyl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -108.380; ZYUIIFJKSLWWHG; [M-H]-; 12-amino-7-oxododecanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.197; YPQLLEPHYDICGQ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -228.298; VPSVFGVVDYMKMK; [M-H]-; 4-octanamidobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.611; WRRYZYASRAUROW; [M-H]-; Decanoylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -322.345; XWYVCQSOGJIMPK; [M-H]-; trans-N-Boc-4-aminomethylcyclohexanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -329.385; KDOINXYPVJQGPE; [M-H]-; 4-Methoxymethylpiperidine-1-carboxylic acid tert-butyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -329.869; RKOVACICPIRRED; [M-H]-; ethyl 4-(dipropylamino)-4-oxobutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -353.590; ZQQHBSPNJHQAKU; [M-H]-; Ethyl 2-(2-(diethylamino)ethyl)acetoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -359.426; DXABICKZWDHPIP; [M-H]-; 1-N-Boc-piperidine-3-ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -379.097; YBNJZIDYXCGAPX; [M-H]-; N-Boc-4-piperidineethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -382.570; DVFBBRGYRFXMCJ; [M-H]-; (E,4R,5R)-4,5-dihydroxy-N-(2-methylpropyl)oct-2-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -387.948; MHDYJJCYEVKSPT; [M-H]-; Hexyl N,N-diethyloxamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -397.143; LTVQOFUGXMVESU; [M-H]-; N-Boc-2-piperidineethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -416.692; GAJBLKYYDVECGZ; [M-H]-; 1-Piperidinecarboxylic acid, 2-(2-hydroxyethyl)-, 2-methylpropyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -431.881; QECNYUPEJKKJSK; [M-H]-; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -453.727; MWQYHQBSFLBACS; [M-H]-; 7,7,9,9-Tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane-2-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -469.229; QLHULAHOXSSASE; [M-H]-; Bayrepel
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -481.871; MMJRNJZURLUGLO; [M-H]-; 2-Methyl-2-propyl-1,3-propanediol 2-methylallylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.556; ZYUIIFJKSLWWHG; [M-H]-; 12-amino-7-oxododecanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -242.149; ZYUIIFJKSLWWHG; [M-H]-; 12-Amino-7-oxododecanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -394.989; VPSVFGVVDYMKMK; [M-H]-; 4-(Octanoylamino)butanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -397.806; MYPCYAJYIBCWHR; [M-H]-; 4-[[(2R)-2-ethylhexyl]amino]-4-oxobutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -403.964; RKOVACICPIRRED; [M-H]-; Succinamic acid, N,N-dipropyl-, ethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -408.413; WRRYZYASRAUROW; [M-H]-; 2-decanamidoacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -426.715; ZQQHBSPNJHQAKU; [M-H]-; Ethyl 2-(2-(diethylamino)ethyl)acetoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -428.030; FXVLUNMZSAJYNE; [M-H]-; tert-butyl N-(2-hydroxycycloheptyl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -441.512; YBNJZIDYXCGAPX; [M-H]-; Tert-butyl 4-(2,2-dideuterio-2-hydroxyethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -442.894; YPQLLEPHYDICGQ; [M-H]-; (1R,2R)-2-[(1S,2S)-2-amino-1-hydroxy-4-methylpentyl]cyclopentanecarboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -451.369; MHDYJJCYEVKSPT; [M-H]-; Hexyl (diethylamino)oxoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.824; ZYUIIFJKSLWWHG; [M-H]-; 12-Amino-7-oxododecanoic acid
COMMENT: CONFIDENCE Level 3: Tentative candidate, 12-Amino-7-oxododecanoic acid, ZYUIIFJKSLWWHG-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0060244;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C12H23NO3
CH$EXACT_MASS: 229.167794
CH$SMILES: C(CCC(=O)CCCCCN)CCC(=O)O
CH$IUPAC: InChI=1S/C12H23NO3/c13-10-6-2-4-8-11(14)7-3-1-5-9-12(15)16/h1-10,13H2,(H,15,16)
CH$NAME: 12-amino-7-oxododecanoic acid
CH$LINK: INCHIKEY ZYUIIFJKSLWWHG-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:4206597
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 9.241
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 228.160496
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004i-0290000000-997781c3934d9d14b116
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  114.9502154 72.6968 114.950253 1.6442 25.94 -0.1909 11 ?
  167.1430942 364.6909 167.143264 0.8077 50.46 0.7967 13 f{C11H19O1}/-6.25ppm,p-C1H3N1O2
  211.1341528 300.2372 211.133729 1.4398 42.30 0.8066 14 f{C12H19O3}/0.87ppm,p-H3N1
  228.1604392 999.0000 228.160209 0.6969 0.00 1.0000 14 f{C12H22N1O3}/-0.34ppm,p
  229.1446015 204.5974 229.144383 1.3834 26.79 0.9231 13 ?
PK$NUM_PEAK: 5
PK$PEAK: m/z int. rel.int.
  114.950215 72.70 72
  167.143094 364.69 364
  211.134153 300.24 300
  228.160439 999.00 999
  229.144601 204.60 204
//
